How MedReleaf’s Production Costs Have Changed Recently

Excluding its fiscal 3Q18, which ended in December 2017, MedReleaf (MEDFF) experienced a fall in its average cost of production on a per-gram basis. This performance was unlike that of producers (HMLSF) Canopy Growth (WEED) and Aurora Cannabis (ACB) (ACBFF), both of which experienced YoY (year-over-year) and sequential falls in their production costs. In fiscal 3Q18, the company’s total cash cost per gram sold increased to 1.83 Canadian dollars from 1.55 Canadian dollars in fiscal 3Q17.